NUVL - Jefferies starts Nuvalent at buy cites lung cancer drug candidates
2024-04-18 09:54:06 ET
More on Nuvalent
- Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024
- Nuvalent lung cancer candidate gets FDA breakthrough therapy status
- Baird starts Nuvalent at outperform, cites potential of lead assets
- Seeking Alpha’s Quant Rating on Nuvalent
- Historical earnings data for Nuvalent